Disclosed positions

Estimated from their latest filings — positions may have changed since

$11.61M

combined est. value

Stock	Shares	Price	Value	Weight	As of
SNDXSyndax Pharmaceuticals Inc	491,690	$23.61	$11.61M	100%	2026-02-09

SNDX

Syndax Pharmaceuticals Inc

$11.61M

491,690 sh

All filings on record

Every Form 4 transaction we track for this filer

all 7buys 0sells 4

Stock	Transaction	Date	~6mo later
SNDXSyndax Pharmaceuticals Inc	Sell $360.8K · 17,159 sh	2026-02-09	—
SNDXSyndax Pharmaceuticals Inc	Sell $152.8K · 7,412 sh	2026-02-06	—
SNDXSyndax Pharmaceuticals Inc	Grant — · 144,600 sh	2026-02-04	—
SNDXSyndax Pharmaceuticals Inc	Grant — · 73,000 sh	2026-02-04	—
SNDXSyndax Pharmaceuticals Inc	Sell $2.58M · 157,307 sh	2025-09-08	—
SNDXSyndax Pharmaceuticals Inc	Exercise $1.71M · 157,307 sh	2025-09-08	—
SNDXSyndax Pharmaceuticals Inc	Sell $70.0K · 7,534 sh	2025-07-16	—

SNDXSell

2026-02-09 · Syndax Pharmaceuticals Inc

$360.8K

—

SNDXSell

2026-02-06 · Syndax Pharmaceuticals Inc

$152.8K

—

SNDXGrant

2026-02-04 · Syndax Pharmaceuticals Inc

144,600

—

SNDXGrant

2026-02-04 · Syndax Pharmaceuticals Inc

73,000

—

SNDXSell

2025-09-08 · Syndax Pharmaceuticals Inc

$2.58M

—

SNDXExercise

2025-09-08 · Syndax Pharmaceuticals Inc

$1.71M

—

SNDXSell

2025-07-16 · Syndax Pharmaceuticals Inc

$70.0K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.